Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that ...
GlobalData on MSN
FDA accepts Otsuka’s centanafadine application for ADHD treatment
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
Sometimes dubbed the 'pleasure chemical', dopamine is often wildly misunderstood. Nikolay Kukushkin delves into what the much ...
You're not lazy. Your ADHD brain is wired for interest, not importance. Discover why necessity doesn't motivate you—and the tricks that actually do.
The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...
Hosted on MSN
Boost dopamine for self-motivation and stay focused
Have you ever wondered why staying motivated feels so much harder for you than it seems to for others? If you’re a woman with ADHD, it’s not just in your head. Prefer to listen rather than read? Press ...
Children with attention deficit hyperactivity disorder (ADHD) do not have a behavioural disorder, nor are they lazy, or lacking in manners and boundaries. Their brains mature in a different way, with ...
If you have ADHD and run a business, you probably know this pattern well. You set a huge exciting goal, sprint for a week or two, then life gets busy and you ghost your own plans. You feel guilty, you ...
This is part 4 of a 5-part series on modern perspectives on ADHD. Part 3, "Is ADHD Really a Disorder?" is available here. If a distinct population of individuals have something we describe as ADHD, ...
Emotional outbursts are a core feature of ADHD, not bad behaviour. A paediatric neurologist explains why children with ADHD ...
This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results